Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFN-11 (Zembrace SymTouch) in Episodic Migraine
NCT02569853Phase 3Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Sep 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sumatriptan in episodic migraine, sponsored by Dr. Reddy's Laboratories. Started Sep 2015; status: completed.
02
Drugs
sumatriptan
03
Conditions
episodic migraine
Beyond the preview
Go deeper on NCT02569853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02569853.